<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Ultragenyx Pharmaceutical Inc. (RARE) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/rare/filings</link>
    <description>Latest company filings for Ultragenyx Pharmaceutical Inc. (RARE) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Fri, 10 Jul 2026 07:48:56 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/rare/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[RARE: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000195004726004713/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-004713</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider sale notice (144) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000192479726000002/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001924797-26-000002</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000179653626000004/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001796536-26-000004</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000171307026000002/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001713070-26-000002</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000139726626000002/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001397266-26-000002</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000138002226000002/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001380022-26-000002</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526229224/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-229224</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526229222/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-229222</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526228639/rare-20260514.htm</link>
      <guid isPermaLink="false">0001193125-26-228639</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Major company event (8-K) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[RARE: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000009375126000302/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000093751-26-000302</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526208632/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-208632</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526206960/rare-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-206960</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Quarterly report (10-Q) on 2026-05-06.]]></description>
      <pubDate>Wed, 06 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[RARE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526206368/rare-20260505.htm</link>
      <guid isPermaLink="false">0001193125-26-206368</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Major company event (8-K) on 2026-05-05.]]></description>
      <pubDate>Tue, 05 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526204402/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-204402</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-05-04.]]></description>
      <pubDate>Mon, 04 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000195004726003887/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003887</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider sale notice (144) on 2026-05-01.]]></description>
      <pubDate>Fri, 01 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[RARE: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000151567326000004/rare_2026_04_30_def14a.htm</link>
      <guid isPermaLink="false">0001515673-26-000004</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Proxy materials (DEFA14A) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[RARE: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000210012126000786/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0002100121-26-000786</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526177470/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-177470</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-04-24.]]></description>
      <pubDate>Fri, 24 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526164308/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-164308</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526164297/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-164297</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526164289/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-164289</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526164281/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-164281</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526164267/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-164267</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526164257/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-164257</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526164247/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-164247</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526140702/xslF345X06/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-140702</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-04-02.]]></description>
      <pubDate>Thu, 02 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526139084/rare-20260402.htm</link>
      <guid isPermaLink="false">0001193125-26-139084</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Major company event (8-K) on 2026-04-02.]]></description>
      <pubDate>Thu, 02 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000195004726003127/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003127</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider sale notice (144) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[RARE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526130498/rare-20260330.htm</link>
      <guid isPermaLink="false">0001193125-26-130498</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Major company event (8-K) on 2026-03-30.]]></description>
      <pubDate>Mon, 30 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[RARE: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000130817926000177/rare015368-ars.pdf</link>
      <guid isPermaLink="false">0001308179-26-000177</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Annual report to shareholders (ARS) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[RARE: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000130817926000175/rare015368-defa14a.htm</link>
      <guid isPermaLink="false">0001308179-26-000175</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Proxy materials (DEFA14A) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[RARE: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm</link>
      <guid isPermaLink="false">0001308179-26-000174</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Proxy statement (DEF 14A) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[RARE: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000010290926002574/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-002574</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[RARE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526103167/rare-20260312.htm</link>
      <guid isPermaLink="false">0001193125-26-103167</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Major company event (8-K) on 2026-03-12.]]></description>
      <pubDate>Thu, 12 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000195004726002450/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-002450</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider sale notice (144) on 2026-03-10.]]></description>
      <pubDate>Tue, 10 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526100309/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-100309</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-03-10.]]></description>
      <pubDate>Tue, 10 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000195004726002334/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-002334</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider sale notice (144) on 2026-03-06.]]></description>
      <pubDate>Fri, 06 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000195004726002108/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-002108</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider sale notice (144) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526089287/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-089287</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526089282/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-089282</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526089278/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-089278</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526089111/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-089111</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526089109/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-089109</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526089107/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-089107</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526089104/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-089104</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526089102/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001193125-26-089102</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider trade (4) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[RARE: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000195004726002038/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-002038</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[RARE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526062568/rare-20260223.htm</link>
      <guid isPermaLink="false">0001193125-26-062568</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Major company event (8-K) on 2026-02-23.]]></description>
      <pubDate>Mon, 23 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[RARE: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526057329/rare-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-057329</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Annual report (10-K) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[RARE: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1515673/000119312526048738/rare-20260212.htm</link>
      <guid isPermaLink="false">0001193125-26-048738</guid>
      <description><![CDATA[Ultragenyx Pharmaceutical Inc. filed a Major company event (8-K) on 2026-02-12.]]></description>
      <pubDate>Thu, 12 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
  </channel>
</rss>